Nasal Lavage Fluid Proteomics Reveals Potential Biomarkers of Asthma Associated with Disease Control
DOI: https://doi.org/10.2147/jaa.s461138
2024-05-17
Journal of Asthma and Allergy
Abstract:Meiping Chen, 1, 2 Yijun Ge, 1, 3 Wen Zhang, 1 Ping Wu, 4 Chao Cao 1 1 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, Ninghai First Hospital, Ningbo, 315600, People's Republic of China; 4 National Facility for Protein in Shanghai, Zhangjiang Lab, Shanghai Advanced Research Institute, CAS, Shanghai, 201210, People's Republic of China Correspondence: Chao Cao, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, 315010, People's Republic of China, Tel +86-574-87089878, Fax +86-0574-8729-1583, Email Purpose: Little research has explored the proteomic characteristics of nasal lavage fluid from asthmatic patients. This study aims to investigate whether differentially expressed proteins (DEPs) in nasal lavage fluid can serve as a biomarker to differentiate asthma patients from healthy controls (HCs) and to discern between individuals with well controlled and poorly controlled asthma. Patients and Methods: We enrolled patients with allergic rhinitis (AR), asthma, or both conditions, and HCs in this study. We recorded patients' demographic and medical history data and administered asthma quality of life questionnaire (AQLQ) and asthma control questionnaire (ACQ). Nasal fluid samples were collected, followed by protein measurements, and proteomic analysis utilizing the data-independent acquisition (DIA) method. Results: Twenty-four with asthma, 27 with combined asthma+ AR, 25 with AR, and 12 HCs were enrolled. Four proteins, superoxide dismutase 2 (SOD2), serpin B7 (SERPINB7), kallikrein-13 (KLK13), and bleomycin hydrolase (BLMH) were significantly upregulated in nasal lavage fluid samples of asthma without AR, compared to HCs (Fold change ≥ 2.0, false-discovery rate [FDR] < 0.05). Conversely, 56 proteins including secretoglobin family 2A member 1 (SCGB2A1) were significantly downregulated (fold change ≥ 2.0, FDR < 0.05). Furthermore, 96.49% of DEPs including peptidase inhibitor 3 (PI3) and C-X-C motif chemokine 17 (CXCL17) were upregulated in poorly controlled asthma patients without AR relative those with well- or partly controlled asthma (fold change ≥ 1.5, FDR < 0.05). Search tool for the retrieval of interacting genes/proteins (STRING) analysis showed that PI3, with 18 connections, may be pivotal in asthma control. Conclusion: The study revealed significant alteration in the nasal lavage proteome in asthma without AR patients. Moreover, our results indicated a potential association between the expression of proteome in the upper airway and the level of asthma control. Specifically, PI3 appears to be a key role in the regulation of asthma without AR. Keywords: allergy, proteomic analysis, nasal lavage fluid, asthma control Graphical Asthma is a chronic inflammatory disorder of the airway, which affected approximately 1–18% of the population, with over 339 million individuals impacted, and poses a major public health concern. 1 Characterized by hyperreactivity of the airway, inflammation, and reversible airflow limitation. 2 The diagnosis and management of asthma largely rely on respiratory symptoms, clinical examination, and lung function test. However, the substantial heterogeneity and complexity of the condition pose challenges in the assessment. In recent years, high-throughput sequencing technology has revolutionized the diagnosis and assessment of respiratory diseases. 3–5 Proteomic techniques have facilitated the quantitative analysis of thousands of proteins and have been utilized to identify disease-specific proteins through molecular and protein pathway analyses. 6 Weitoft et al research identified 150 proteins in asthmatic subjects that significantly changed following respiratory challenge with inhaled allergens. 7 Notably, coagulation factor XIII, which is impacted in macrophage polarization and associated with airflow limitation, 8,9 was among these proteins. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis has further revealed seven proteins, such as alpha1-microglobulin bikunin [AMBP], insulin-like growth factor-binding protein complex acid labile subunit [IGFALS], kininogen-1 [KNG1], and others, which were differentially expressed in asthma patients compared to healthy controls (HCs). 10 Sputum proteomics has unveiled -Abstract Truncated-
immunology,allergy,respiratory system